Atria Investments’s Journey Medical DERM Stock Holding History

Atria Investments’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.8K	Buy	14,451 +1,374	+11%	+$10.7K	﹤0.01%	2019
2025 Q4	$101K	Sell	13,077 -12,553	-49%	-$98.4K	﹤0.01%	2003
2025 Q3	$182K	Sell	25,630 -11,555	-31%	-$83.8K	﹤0.01%	1962
2025 Q2	$267K	Sell	37,185 -7,474	-17%	-$51.7K	﹤0.01%	1776
2025 Q1	$263K	Buy	44,659 +1,214	+3%	+$5.97K	﹤0.01%	1694
2024 Q4	$170K	Sell	43,445 -952	-2%	-$5.2K	﹤0.01%	1806
2024 Q3	$251K	Sell	44,397 -10,940	-20%	-$56.3K	﹤0.01%	1708
2024 Q2	$312K	Buy	+55,337	New	+$228K	﹤0.01%	1563

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Atria Investments's DERM Position: Q1 2026 in Review

Atria Investments increased its Journey Medical (DERM) stake by 11% in Q1 2026, buying an estimated $10.7K and bringing the position to 14,451 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

Atria Investments first reported a position in DERM in Q2 2024 and has held it in 8 quarters since. The position peaked at $312K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

Atria Investments held 14,451 shares of Journey Medical worth $67.8K as of Q1 2026.
Atria Investments bought 1,374 Journey Medical shares in Q1 2026, an estimated $10.7K.
Journey Medical made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #2019 holding.
Atria Investments first reported a position in Journey Medical in Q2 2024 and has held it in 8 quarters since.
Atria Investments's Journey Medical position peaked at $312K in Q2 2024.
71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.